DSDodi Safari

Dodi Safari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dodi Safari has a total of 349 co-authors. Here are the top co-authors by number of shared publications:

  • Korrie Salsabila

    Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Bogor, Indonesia

    18 shared publications
  • Wisnu Tafroji

    Infectious Diseases and Immunology Research Center. Indonesian Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

    18 shared publications
  • Miftahuddin Majid Khoeri

    Eijkman Research Center for Molecular Biology, The National Research and Innovation Agency, Cibinong Science Center, Bogor, Indonesia; Doctoral program in Biomedical, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia

    16 shared publications
  • Wisnu Tafroji

    Infectious Diseases and Immunology Research Cluster, Indonesia Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Indonesia

    14 shared publications
  • Ageng Wiyatno

    Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia

    11 shared publications
  • Amin Soebandrio

    Department of Clinical Microbiology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia

    11 shared publications

Latest Publications

  • Open Access

    Surveillance for zoonotic viruses in human population at the human-animal interface in North Sulawesi, Indonesia

    by Ageng Wiyatno, Tina Kusumaningrum, Aghnianditya Kresno Dewantari, Alice Latinne, Citra Livi Kowel, Lidia Gaghiwu, Janno B. B. Bernadus, Berounly Star Rey, Maya Chintya Rambitan, Ungke Anton Jaya, et al.

  • Open Access

    Widespread Occurrence and Whole-Genome Characterization of ESBL-producing Escherichia coli in Urban and Rural Water Environments in Indonesia

    by Yudith Paramitadevi, Iftita Rahmatika, Cindy Rianti Priadi, Arina Apriyana, Dodi Safari, Nurul Komarudin, Rosantia Sarassari, Yustinus Maladan, Fahrunnisa Fahrunnisa

    Extended-spectrum β-lactamase-producing Escherichia coli are important indicators of antimicrobial resistance dissemination across human, animal, and environmental compartments. This study investigated their occurrence, concentration, genomic diversity, resistance determinants, virulence profiles, and plasmid replicons in urban and rural aquatic environments in Indonesia. Water samples were collected from the Ciliwung River across Bogor, Depok, and Jakarta; the Citarum River in West Java; the Brang Biji River in Sumbawa; groundwater wells in Depok,; and the influent and effluent of domestic and hospital wastewater treatment plants discharging into the Ciliwung River. ESBL-producing E. coli were detected at all Ciliwung River sites, seven of ten Citarum River sites, six of twenty-seven Brang Biji River sites, and three of five groundwater wells. The Ciliwung River had the highest mean concentration, at (2.1 ± 2.9) × 10⁴ CFU/100 mL, with an approximately 27-fold increase from upstream to downstream. Genomic analysis revealed a highly heterogeneous population structure, including the clinically relevant lineage ST361 and several sequence types shared between wastewater, river water, and groundwater, suggesting connectivity among these compartments. Isolates carried clinically important resistance genes, including blaCTX-M-15, blaCTX-M-55, qnrS, sul, and tetA, and virulence markers associated with uropathogenic, adherent-invasive, enterotoxigenic, and extraintestinal pathogenic E. coli. Diverse plasmid replicons, particularly IncF, IncI1-Iα, IncHI1, and Col types, indicated substantial potential for horizontal gene transfer. These findings demonstrate that Indonesian rivers, wastewater effluents, and groundwater constitute interconnected reservoirs of clinically relevant ESBL-producing E. coli. Environmental and wastewater surveillance should therefore be integrated into national One Health AMR monitoring and water-safety interventions.

  • Open Access

    A review on monitoring emerging viruses in Indonesia in the post-COVID-19 era

    by Ageng Wiyatno, Khin Saw Myint, I. Made Artika, Aghnianditya Kresno Dewantari, Korri El Khobar, Amalina Ghaisani Komarudin, Amin Soebandrio, Dodi Safari

  • Genomic and molecular dynamics analysis of mefA-encoded macrolide efflux protein from Tn2009 and Tn2010 in Streptococcus pneumoniae

    by Yustinus Maladan, Endah Retnaningrum, Budi Setiadi Daryono, Ratna Fathma Sari, Dodi Safari

    Antibiotic resistance in Streptococcus pneumoniae remains a major clinical challenge, particularly for macrolides such as erythromycin. This resistance is commonly associated with transposons Tn2009 and Tn2010 carrying the mefA gene, which encodes a macrolide efflux protein. This study investigated the genetic characteristics of mefA from Indonesian clinical isolates and elucidated its efflux mechanism using integrated genomic analysis and molecular dynamics simulations. Whole-genome sequencing confirmed the presence of Tn2009 and Tn2010 in clinical isolates. Multiple sequence alignment showed high conservation of mefA (98–100% identity), indicating strong evolutionary stability within the species. A homology model of the mefA encoded efflux protein was constructed and used for molecular docking, revealing stable erythromycin binding within the efflux channel with multiple favorable binding poses. Molecular dynamics simulations (200 ns) demonstrated structural stability of the protein, with an average root mean square deviation of 0.174 nm. Root mean square fluctuation analysis identified localized flexibility in residues Asn195–Ser199, suggesting a functionally relevant intracellular loop involved in conformational dynamics. Despite stable interactions, erythromycin remained confined within a localized channel region and did not undergo spontaneous translocation under equilibrium conditions. Steered molecular dynamics simulations indicated that ligand transport requires external force to overcome an initial energetic barrier of 553.07 kJ/mol/nm, followed by stepwise displacement through multiple transient binding sites, consistent with a multi-site relay mechanism. Umbrella sampling further revealed a rugged free energy landscape, with a maximum potential of mean force (PMF) of ~ 45 kcal/mol near the channel exit region. The PMF profile, reconstructed using WHAM across ~ 30 windows, showed well-converged overlap and multiple intermediate minima, indicating a stable sampling of the reaction coordinate. Collectively, these findings provide structural and energetic insights into mefA mediated erythromycin resistance in S. pneumoniae. The results support a mechanism involving stable substrate binding, localized conformational flexibility, and substantial energy barriers requiring active transport, highlighting potential targets for efflux inhibition strategies.

  • Open Access

    Genomic and phenotypic characterization of a multidrug-resistant Streptococcus pneumoniae 19 F ST320 isolate from a pediatric SARS-CoV-2 case in Yogyakarta, Indonesia

    by Tiara Putri, Budi Setiadi Daryono, Endah Retnaningrum, Eko Agus Suyono, Wisnu Tafroji, Yustinus Maladan, Dodi Safari, Sven Hammerschmidt

    Multidrug-resistant Streptococcus pneumoniae remains a major concern in Southeast Asia, yet genomic data from Indonesia are limited. Among 19 pediatric patients with suspected COVID-19 in Yogyakarta, we identified a single pneumococcal isolate, GD-BC-10, from a SARS-CoV-2–positive child. The isolate was serotyped as 19 F and was assigned to sequence type (ST) 320, which is a member of the globally disseminated clonal complex (CC) 320/271. This 19 F strain exhibits resistance to multiple drug classes, including β-lactams, macrolides, tetracyclines, lincosamides, and folate-pathway inhibitors. Whole genome sequencing revealed resistance determinants characteristic of ST320 isolates within the CC320/271 lineage, defined by the 13-11-16 allelic combination across pbp1a, pbp2b, and pbp2x, together with erm(B), mef(A), tet(M), and folA/folP determinants. Virulence profiling identified a wide array of adhesion and immune-evasion factors including both PI-1 and PI-2 pilus islets, consistent with high-fitness of pediatric lineages. Although derived from a single carrier, the genomic and phenotypic features of this isolate reflect the persistence of high-risk 19 F clones in Indonesia. These findings emphasize the need for strengthened genomic surveillance and targeted genotypic assays to support pneumococcal monitoring in pediatric clinical settings.

  • Open Access

    Unveiling the prevalence of macrolide resistance genes in Streptococcus pneumoniae isolates from Indonesia

    by Ratna Fathma Sari, Yustinus Maladan, Rosantia Sarassari, Sarah Azhari Balqis, Ghina Athyah Wahid, Korrie Salsabila, Finny Fitry Yani, Ari Prayitno, Dodi Safari

    The effectiveness of macrolides in the treatment of pneumococcal infections has been increasingly challenged by the emergence and spread of antibiotic resistance mechanisms. This study aims to determine the prevalence of macrolide resistance genes (mefA and ermB) among Streptococcus pneumoniae isolates from selected regions of Indonesia. A total of 703 archived S. pneumoniae isolates were screened for both genes using polymerase chain reaction. A total of 11% and 4% isolates were positive for mefA and ermB, respectively. The major serotype carrying the mefA gene was 19F (48%), followed by serotype 23F (39%). The predominant serotype containing the ermB genes was 19F (17%). The occurrence of macrolide resistance in S. pneumoniae in Indonesia shows a notable pattern, with the most prominent presence observed in serotype 19F.

  • Open Access

    The antimicrobial profile and phylogenomic analysis of serotype 1 Streptococcus pneumoniae in Indonesia

    by Dewi Anastasia Christina, Yustinus Maladan, Diana Shintawati Purwanto, Dodi Safari

    Serotype 1 pneumococcus is commonly associated with antimicrobial resistance and is a leading cause of respiratory infections and meningitis in infants, despite years of pneumococcal conjugate vaccine (PCV) immunization in Africa. This report provides a genome overview of serotype 1 Streptococcus pneumoniae, a rare serotype that colonized Indonesia before the introduction of PCV13, and shared the same strain as those commonly found in Africa. We conducted genomic analyses on the whole-genome sequencing data. In addition to sulfamethoxazole/trimethoprim resistance, we found transposon-mediated resistance to chloramphenicol and tetracycline, indicating multidrug resistance. The phylogenomic analysis revealed that serotype 1 from Indonesia was more closely related to isolates from Cambodia than to those from Africa. We identified virulence factor, competence, and quorum-sensing genes. This is a foundational study that describes a sequenced sample of serotype 1 pneumococcal carriage in Indonesia, uses a genomic approach, and compares it with other countries through phylogenomic analysis.

  • Open Access

    Metagenomic Analysis of Thoracic Empyema Etiology Through Next-Generation Sequencing Enhances Conventional Culture Techniques

    by Dewi Anggraini, Indra Yovi, Aisyah Elliyanti, Dodi Safari, Nur Afrainin Syah, Afif Pranaya Jati, Rosantia Sarassari, Elvando Tunggul Mauliate Simatupang

    This study aimed to analyze the microbiome of thoracic empyema using metagenomic methods and compare the results with conventional culture methods to increase diagnostic accuracy and enhance antibiotic therapy. This study involved 30 patients with thoracic empyema from hospitals in Riau Province, Indonesia. Pleural fluid samples were collected for culture analysis and identification using the Vitek 2 compact system and metagenomic analysis. Patient clinical data were also collected. Culture methods showed a 40.0% positive rate, with Gram-negative bacteria (Klebsiella pneumoniae and Pseudomonas aeruginosa) predominating. Metagenomics showed a 56.7% positive rate, identifying a more diverse microbiome, including fungi (29.4% abundance), other Gram-negative bacteria (26.5%), and anaerobic bacteria (22.5%). Comparison of the two methods showed 36.7% complete agreement and 23.3% partial agreement, with 40% disagreement, with a Kappa coefficient of 0.416 and P-value of 0.016 (P<0.050). Metagenomic NGS offers significant advantages in detecting the microbiome of thoracic empyema, particularly fungi and anaerobic bacteria, which are often missed by conventional culture methods. This has the potential to improve diagnostic accuracy and optimize antibiotic therapy. Further research with larger sample sizes is needed.

    • 1 October 2025
      • Vol. 57  (4) , 503-507

    Complicated Thoracic Empyema of Serotype 23F Streptococcus pneumoniae in an Adult Patient.

    by Indra Yovi, Dodi Safari, Nur Afrainin Syah, Dewi Anggraini, Rosantia Sarassari, Yustinus Maladan, Ayummi Azzahrah, Nicholas Gilbert Pelawi, Aisyah Elliyanti

    We report a case of thoracic empyema in a 61-year-old male patient, a heavy smoker with malignancy undergoing chemotherapy. The patient's clinical symptoms included shortness of breath, productive cough, fever, and chest pain. This patient had never received antibiotics before. Streptococcus pneumoniae was isolated from a bedside culture of empyema fluid collected through thoracentesis. The empyema fluid was cultured on chocolate agar plates and in aerobic and anaerobic culture bottles. The isolate was identified as serotype 23F, a vaccine strain with sequence type 17532. The isolate was resistant to chloramphenicol, tetracycline, and cotrimoxazole. The patient clinically improved with the administration of combined intravenous ceftriaxone and levofloxacin antibiotics, along with chest tube drainage via thoracostomy. This is the first report of thoracic empyema caused by S. pneumoniae in an adult in Indonesia. Serotype 23F is multi-resistant with low invasiveness, typically causing infections in patients with underlying health conditions. The pneumococcal conjugate vaccine covers it; thus, it usually occurs in areas with low vaccine coverage. Our findings support the importance of improving adult pneumococcal vaccination coverage in Indonesia.

  • Open Access

    Viral–bacterial codetection among patients with pneumonia during the coronavirus disease 2019 pandemic in Jakarta, Indonesia

    by Ageng Wiyatno, Khin Saw Myint, I Made Artika, Amin Soebandrio, Dodi Safari

    Pneumonia is a leading cause of death worldwide, especially among children and the elderly, mainly due to viral and bacterial infections. During the coronavirus disease 2019 pandemic, cases rose as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) also causes pneumonia. This study investigates viral and bacterial detection among SARS-CoV-2-suspected patients with pneumonia admitted to the health care facilities in Jakarta, Indonesia. Of the 245 pneumonia cases, 80 (33%) were confirmed positive for SARS-CoV-2. Among other viruses, paramyxovirus and herpesvirus were the predominant viruses identified (each 7%) followed by influenza virus (5%) and enterovirus (2%). Bacterial screening of nasopharyngeal swab specimens detected 21 (9%) and 14 (6%) positive for Haemophilus influenzae and Streptococcus pneumoniae, respectively. Overall, the higher rate of viral–bacterial codetection was observed in the SARS-CoV-2-positive cases than in the negative cases. We found that viral–bacterial codetection was not significantly associated with clinical manifestation, patient outcome or severity.